Shaping the Future: Eli Lilly's Role in the Weight Management Revolution
Read Now!
Online
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
Data Library
Academic Downloads
Interaction Checker
Get More
Navigate to
DrugBank.com
to check out our commercial products, use cases and more!
DrugBank For Clinical Software
Clinical API
Clinical intelligence tool for your software
Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Drug Allergy
Get drug allergy and cross sensitivities info
US Drug Labels
Integrate drug manufacturer information
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Recurrent Disease
Also known as:
Recurrent disease (finding)
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB08916
Afatinib
0
Recruiting
1
DB01254
Dasatinib
0
Recruiting
1
DB01590
Everolimus
0
Recruiting
1
DB09074
Olaparib
0
Recruiting
1
DB09073
Palbociclib
0
Recruiting
1
DB00928
Azacitidine
1
Completed
1
DB05015
Belinostat
1
Completed
1
DB00188
Bortezomib
1
Completed
1
DB16741
Bortezomib D-mannitol
1
Completed
1
DB00987
Cytarabine
1
Active Not Recruiting
1
DB00997
Doxorubicin
1
Active Not Recruiting
1
DB00741
Hydrocortisone
1
Active Not Recruiting
1
DB00563
Methotrexate
1
Active Not Recruiting
1
DB09073
Palbociclib
1
Active Not Recruiting
1
DB00059
Pegaspargase
1
Active Not Recruiting
1
DB00860
Prednisolone
1
Active Not Recruiting
1
DB00635
Prednisone
1
Active Not Recruiting
1
DB04960
Tipifarnib
1
Completed
1
DB00541
Vincristine
1
Active Not Recruiting
1
DB17327
Zalsenertant tetraxetan lutetium Lu-177
1
Terminated
1
DB06643
Denosumab
1 / 2
Completed
1
DB00398
Sorafenib
1 / 2
Completed
1
DB04960
Tipifarnib
1 / 2
Completed
1
DB11885
Anlotinib
2
Unknown Status
1
DB06769
Bendamustine
2
Unknown Status
1
DB11666
Buparlisib
2
Completed
1
DB00002
Cetuximab
2
Recruiting
1
DB00002
Cetuximab
2
Terminated
1
DB00091
Cyclosporine
2
Completed
2
DB01254
Dasatinib
2
Completed
1
DB01248
Docetaxel
2
Terminated
1
DB17160
Edotreotide yttrium Y-90
2
Terminated
1
DB01073
Fludarabine
2
Completed
2
DB09053
Ibrutinib
2
Unknown Status
1
DB00619
Imatinib
2
Completed
1
DB00688
Mycophenolate mofetil
2
Completed
2
DB04868
Nilotinib
2
Completed
1
DB16747
Penpulimab
2
Recruiting
1
DB00073
Rituximab
2
Unknown Status
1
DB01268
Sunitinib
2
Terminated
1
DB17459
Therapeutic allogeneic lymphocytes
2
Completed
2